Sequent Scientific is an API manufacturer based in India. It holds 4 valid CEPs across a filed portfolio of 4 molecules. Its filings concentrate with MCAZ (ZW) and MINSA (CR). Customs aggregates show $6.0M of exports covering 158 molecules to 24 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Mumbai, India | Not on file |
| Hyderabad, India | Not on file |
| Thane, India | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Albendazole | EDQM, SFDA (Saudi Arabia) | 3 |
| Flunixin Meglumine For Veterinary Use | EDQM | 1 |
| Ketoprofen | EDQM | 1 |
| Praziquantel | EDQM | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| MCAZ (ZW) | 1 | None |
| MINSA (CR) | 1 | None |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $1.3M | 12 |
| 2025 | Not reported | $6.0M | 24 |
| 2024 | Not reported | $3.7M | 26 |
| 2023 | Not reported | $2.5M | 21 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Sequent Scientific comes back tiered against every other supplier able to file there.
Start for free